Chiropractors in Pleasant Valley, NY Accepting Medicare

5 Chiropractors found. Showing 1 - 5

Back To Health Medicine And Diagnostics Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 1395 Route 44, Pleasant Valley, NY 12569 Phone: 845-635-5002    Fax: 845-635-5295

Valley Chiropractic Assoc Pc Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 1579 Main St, Pleasant Valley, NY 12569 Phone: 845-635-8484    Fax: 845-635-8491

Dr. Jay Decesare, DC Chiropractor Medicare: Accepting Medicare Assignments Practice Location: Rt 44/55, Pleasant Valley, NY 12569 Phone: 845-635-5002    Fax: 845-635-5295

Dr. Joseph Detullio, DC Chiropractor Medicare: Not Enrolled in Medicare Practice Location: Rt 44 And North Ave, Pleasant Valley, NY 12569 Phone: 845-635-1200    Fax: 845-635-1637

Mr. Mark Goldhirsch, DC Chiropractor Medicare: May Accept Medicare Assignments Practice Location: 1395 Rt 44, Pleasant Valley, NY 12569 Phone: 845-635-5002    Fax: 845-635-5295

News Archive

Virtual colonoscopy is an accurate screening method for colorectal cancer

"Our positive experience with virtual colonoscopy screening covered by health insurance demonstrates its enormous potential for increasing compliance for colorectal cancer prevention and screening"

Given Imaging includes Aptina's image sensor in its PillCam capsule

Aptina announced today that Given Imaging Ltd.'s PillCam® COLON 2 includes Aptina's MT9S526 medical image sensor. All three of Given Imaging's patient-friendly, ingestible PillCam® products for small bowel, esophageal, and now colon imaging include Aptina's sensors embedded within the Given Imaging capsules.

Study examines link between breath, cancer detection

A test using a patient's breath could be developed to detect lung, breast, bowel and prostate cancers, a team of scientists have discovered. While these results are only preliminary, the study1 published in the British Journal of Cancer today (Wednesday), found that sensors could distinguish between the breath of healthy patients and those who have cancer.

Aptus Endosystems announces completion of $15M Series AA financing

Aptus Endosystems, Inc., a medical device company developing advanced technology for endovascular aneurysm repair, announced the completion of a $15 million Series AA financing. U.S. Venture Partners and Longitude Capital led the round in continuation of their commitment to Aptus' innovative technologies for the treatment of aortic aneurysms.

Discovery sheds new light on biological phenomenon in autoimmune disease

A newly-unveiled discovery, which has been four years in the making, has the potential to change the way we look at autoimmune diseases and understand how and why immune cells begin to attack different tissues in the body.

Read more Medical News

› Verified 7 days ago